title: Risperidone-associated increase in triglyceride levels.
authors.forename: Andrea
authors.initials: A
authors.lastname: Weinbrenner
authors.forename: Verena
authors.initials: V
authors.lastname: Peus
authors.forename: Dragos
authors.initials: D
authors.lastname: Inta
authors.forename: Susanne
authors.initials: S
authors.lastname: Englisch
authors.forename: Mathias
authors.initials: M
authors.lastname: Zink
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001835:Body Weight / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000139:chemically induced; D015228:Hypertriglyceridemia / Q000097:blood / Q000139:chemically induced*; D008297:Male; D011569:Psychiatric Status Rating Scales; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy*; D014280:Triglycerides / Q000097:blood*
chemical_list: D014150:Antipsychotic Agents; D014280:Triglycerides; D018967:Risperidone